7.75
Precedente Chiudi:
$7.48
Aprire:
$7.23
Volume 24 ore:
148.60K
Relative Volume:
0.32
Capitalizzazione di mercato:
$12.29M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-6.7391
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
+81.07%
1M Prestazione:
+79.81%
6M Prestazione:
+9.37%
1 anno Prestazione:
-81.28%
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Nome
Acurx Pharmaceuticals Inc
Settore
Industria
Telefono
917-533-1469
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Confronta ACXP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ACXP
Acurx Pharmaceuticals Inc
|
7.752 | 11.85M | 0 | -14.58M | -9.80M | -1.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
406.99 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
472.31 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
551.43 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
330.74 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
Will Acurx Pharmaceuticals Inc. stock split attract more investors2025 Price Targets & Weekly High Momentum Picks - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock test all time highsJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Multi factor analysis applied to Acurx Pharmaceuticals Inc.Weekly Volume Report & Low Risk Entry Point Tips - newser.com
Acurx Pharmaceuticals Inc.’s volatility index tracking explainedMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group - Myrtle Beach Sun News
Acurx Pharmaceuticals (NASDAQ:ACXP) Raised to Hold at Wall Street Zen - Defense World
How Acurx Pharmaceuticals Inc. (3ZO) stock reacts to fiscal policiesWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Acurx Pharmaceuticals granted Australian patent for antibiotics - Investing.com Australia
Acurx Pharmaceuticals granted Australian patent for antibiotics By Investing.com - Investing.com Nigeria
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors - Stock Titan
Measuring Acurx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
What drives Acurx Pharmaceuticals Inc stock pricePrice-to-Earnings Ratio Insights & High Return Market Tips - earlytimes.in
Pharma Boom: Acurx on the Rise - StocksToTrade
ACXP’s Steady Climb: New Developments? - timothysykes.com
90% Plunge to 1000% Upside? Acurx Pharmaceuticals (ACXP) Stock Sees EMA Boost & Bold Analyst Predictions - ts2.tech
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Corpus Christi Caller-Times
Will breakout in Acurx Pharmaceuticals Inc. lead to full recoveryPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Acurx Pharmaceuticals Inc Stock Analysis and ForecastInterest Rate Changes & Build Capital Safely - earlytimes.in
How supply shortages influence Acurx Pharmaceuticals Inc. (3ZO) stockInsider Buying & Weekly Stock Performance Updates - newser.com
Acurx Pharmaceuticals Inc. stock trendline breakdownChart Signals & Long-Term Investment Growth Plans - newser.com
Why retail investors favor Acurx Pharmaceuticals Inc. stockPortfolio Gains Report & Reliable Breakout Stock Forecasts - newser.com
Will Acurx Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - newser.com
New to The Street to Broadcast Nationwide on Bloomberg Tonight at 6:30 PM EST - Sacramento Bee
Acurx Pharmaceuticals (NASDAQ:ACXP) Lowered to Sell Rating by Wall Street Zen - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock return to pre crash levels2025 Price Action Summary & Comprehensive Market Scan Insights - newser.com
Chart overlay techniques for tracking Acurx Pharmaceuticals Inc.2025 Support & Resistance & Consistent Profit Alerts - newser.com
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
Acurx Pharmaceuticals stock maintains Buy rating at H.C. Wainwright - Investing.com
EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat By Investing.com - Investing.com Nigeria
Acurx Pharmaceuticals (NASDAQ:ACXP) Given “Buy” Rating at HC Wainwright - Defense World
H.C. Wainwright Maintains Acurx Pharmaceuticals(ACXP.US) With Buy Rating, Maintains Target Price $31 - 富途牛牛
Promising Outlook for Acurx Pharmaceuticals: Buy Rating Driven by Regulatory Milestones and Clinical Success of Ibezapolstat - TipRanks
EMA approves Acurx’s pediatric plan for C. difficile drug ibezapolstat - Investing.com
Acurx Pharmaceuticals, Inc. Announces Positive Opinion from EMA on Pediatric Investigation Plan for Ibezapolstat Use in Children with C. Difficile Infection - MarketScreener
DYAI Stock Analysis and ForecastVolume Profile Analysis & Start Investing With Free Smart Watchlists - earlytimes.in
20,000 Children Affected Annually: Acurx's New Antibiotic Gets Key EMA Support for C. difficile Treatment - Stock Titan
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Acurx Pharmaceuticals Inc Azioni (ACXP) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):